Treatment with 3BrPA at 50 μM suppressed ATP production markedly in CD138+ primary MM cells as in RPMI8226 cells but only partially in normal CD138- bone marrow cells and PBMCs (Figure 1C–D). Here, SDC1 is linked to Miyoshi myopathy.